22 December 2024AmericasBethan Hopewell, Partner, Powell Gilbert/Joel Coles, Partner, Powell Gilbert/Siddharth Kusumakar, Partner, Powell Gilbert

WATCH: The European IP landscape

Bethan Hopewell, Joel Coles, and Siddharth Kusumakar, partners at Powell Gilbert, discuss the significant developments in the European patent landscape in 2024, not only at the UPC but also at the EPO.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Masimo convinces judge that Apple took secrets—but it’s not enough

19 March 2026 Although the court agreed that the tech giant misappropriated some of Masimo’s information related to pulse oximetry technology, Apple is not barred from using it, says a California judge.

Americas

J&J unit targets former employee over alleged mass data theft

17 March 2026 Janssen seeks injunctive relief after a forensic review uncovers mass downloads of trade secrets spanning oncology, neuroscience and immunology portfolios.

Americas

Mylan withdraws defence claims against Novo in Wegovy dispute

13 March 2026 A proposed judgment by the rivals would extend the period in which Mylan is barred from obtaining regulatory approval for its generic of the weight-loss injectable.

More features

Masimo convinces judge that Apple took secrets—but it’s not enough

J&J unit targets former employee over alleged mass data theft

Mylan withdraws defence claims against Novo in Wegovy dispute

Six Summit takeaways: In-person IP, agentic AI and ‘infollution’ risks

Astellas blocks generic version of key urology drug until 2030

GSK inks licensing deal for liver disease drug

Novo ends Hims & Hers dispute with deal for blockbuster weight-loss drugs

Medtech Magnolia fails to revive $2.1m verdict at Fed Circ

WATCH: The European IP landscape

More on this story

Editor's picks

Editor's picks

More features